Scientific Advisors
-
George L. Drusano, MD
Dr. Drusano is Co-director of the Ordway Research Institute, Albany, NY, Co-director of the Center for Biodefense and Emerging Infections, Ordway Research Institute, Albany, NY, Co-chief of the Bacterial and Fungal Emerging Infections and Pharmacodynamics Laboratory, Ordway Research Institute, and Professor at the Albany Medical College, Albany, NY. Dr. Drusano is a Fellow of the Infectious Diseases Society of America, a Fellow of the American Academy of Microbiology and is President of the International Society for Anti-infective Pharmacology (ISAP). In 1991, he was the recipient of the Rhone-Poulenc Award for the most innovative research with fluoroquinolones. In 1998 he received the American Society of Health System Pharmacy Research and Education Foundation Drug Therapy Research Award for outstanding contribution to the scientific pharmaceutical literature. Dr. Drusano is one of the most highly recognized world experts in the area of anti-infective pharmacodynamics. His well-recognized work correlates in vivo efficacy in pharmacodynamic models with clinical efficacy, using Monte Carlo simulations to provide high predictivity in determining effective clinical doses for antibiotics in almost all classes.
-
Donald E. Low, M.D., FRCPC
Dr. Low is Microbiologist-in-Chief, Department of Microbiology, Mount Sinai Hospital, Toronto, ON, Canada. He is a Professor at the University of Toronto in the Department of Laboratory Medicine and Pathobiology and Department of Medicine and is currently Head of the Division of Microbiology in the Department of Laboratory Medicine and Pathobiology. Dr. Low is also a fellow of the Royal College of Physicians and Surgeons of Canada, and a Fellow of the American Academy of Microbiology. Dr. Low's primary research interests are in the study of the epidemiology and the mechanisms of antimicrobial resistance in community and hospital pathogens. Other research interests include the epidemiology, pathogenesis, and treatment of streptococcal diseases. Dr. Low is a reviewer for several organizations including the Medical Research Council, Health and Welfare Canada, New England Journal of Medicine, Journal of American Medical Association, and the Proceedings of the National Academy of Science. He is also an Associate Editor of the Canadian Journal of Infectious Diseases.
-
Robert C. Moellering Jr., MD
Dr. Moellering is the Shields Warren-Mallinckrodt Professor of Medical Research at Harvard Medical School. He served as Physician-in-Chief at the New England Deaconess Hospital from 1981 until 1996. He subsequently served as the Herrman L. Blumgart Professor of Medicine at Harvard Medical School, and Physician-in-Chief and Chairman of the Department of Medicine at the Beth Israel Deaconess Medical Center (BIDMC) in Boston through 2005. During that period he was also President and CEO of Harvard Medical Faculty Physicians at BIDMC. Dr. Moellering’s main research interests include mechanisms of resistance to new antibacterial agents, mechanisms of resistance to glycopeptides and their relationship to virulence in MRSA and prokaryote/eukaryote interactions. He is a Fellow of the Infectious Diseases Society of America, Master of the American College of Physicians, an Honorary Fellow of the Royal College of Physicians, and has been elected to membership in the American Society for Clinical Investigation and the Association of American Physicians. He is Editor-in-Chief Emeritus of Antimicrobial Agents and Chemotherapy, Consulting Editor of Infectious Disease Clinics of North America, and Associate Editor of the Journal of Infection and Public Health. Dr. Moellering has received many prestigious awards, most recently the 2008 Alexander Fleming Award for Lifetime Achievement from the Infectious Diseases Society of America.
-
Jack S. Remington, MD
Dr. Remington is Professor of Medicine, Stanford School of Medicine, Division of Infectious Diseases and Geographic Medicine, and Marcus A Krupp Research Chair and Chairman, Department of Immunology and Infectious Diseases, Research Institute of Palo Alto Medical Foundation (PAMF) Palo Alto, CA. Dr. Remington is a past President of the Infectious Disease Society of America. Dr. Remington is a nationally and internationally recognized authority in the field of infectious disease medicine, and has received numerous awards including the Gold Medal from the Royal College of Physicians, London, England in 1999 and the 1996 Bristol Award of the Infectious Disease Society of America. In nearly four decades as head of the Research Institute's Department of Immunology and Infectious Diseases, Dr. Remington has become world-renowned for his pioneering work as a clinician, researcher and teacher. His research has led to major advances in the understanding, diagnosis and treatment of toxoplasmosis (an infection caused by T. gondii), and also the creation of the Toxoplasma Serology Laboratory at PAMF, the leading reference laboratory for the United States and much of the world. By using T. gondii as a scientific model, Dr. Remington and his colleagues have unlocked many secrets to the overall process of infection and the body's defenses against it. A major clinical focus of Dr. Remington's has been the study of infections in patients with suppressed immune systems, including those with cancer, organ transplants or AIDS.
Duo an num quam fuisset sadipscing, elit animal doc endi enum num ut.